Suchergebnisse - "Serra-Burriel, Miquel"

PubPharm (84)

1

Screening for liver fibrosis : lessons from colorectal and lung cancer screening

enthalten in: Nature reviews. Gastroenterology & hepatology | 2024

von Thiele, M. | Kamath, P. | Graupera, I. | +5

2

Patients on vitamin K treatment : is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort

enthalten in: Open heart | 2024

von Aebersold, H. | Foster-Witassek, F. | Aeschbacher, S. | +24

3

Novel prognostic biomarkers in decompensated cirrhosis : a systematic review and meta-analysis

enthalten in: Gut | 2023

von Juanola, A. | Ma, A. | de Wit, K. | +65

4

Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation : A Target Trial Approach

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2023

von Serra-Burriel, M. | Aebersold, H. | Foster-Witassek, F. | +16

5

Longitudinal Changes in Health-Related Quality of Life in Patients With Atrial Fibrillation

enthalten in: Journal of the American Heart Association | 2023

von Foster-Witassek, F. | Aebersold, H. | Aeschbacher, S. | +22

6

Regulatory Review Duration and Differences in Submission Times of Drugs in the United States and Europe, 2011 to 2020

enthalten in: Annals of internal medicine | 2023

von Vokinger, K. | Serra-Burriel, M. | Glaus, C. | +4

7

Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population : a multicohort study

enthalten in: Lancet (London, England) | 2023

von Serra-Burriel, M. | Juanola, A. | Serra-Burriel, F. | +157

ErratumIn: Lancet. 2023 Sep 16;402(10406):964. - PMID 37716767

8

Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controls

enthalten in: BMJ open | 2023

von Aebersold, H. | Foster-Witassek, F. | Serra-Burriel, M. | +23

9

The cancer premium - explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland : a cross sectional study

enthalten in: EClinicalMedicine | 2023

von Serra-Burriel, M. | Perényi, G. | Laube, Y. | +2

10

Therapeutic value of first versus supplemental indications of drugs in US and Europe (2011-20) : retrospective cohort study

enthalten in: BMJ (Clinical research ed.) | 2023

von Vokinger, K. | Glaus, C. | Kesselheim, A. | +3

CommentIn: BMJ. 2023 Jul 5;382:1466. - PMID 37407080

1
2
3
4
5
6
7
8
9
Nächster »
[9]